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Background: Parasitic nematodes can cause substantial clinical and subclinical problems in alpacas and
anthelmintics are regularly used to control parasitic nematodes in alpacas. Although anthelmintic resistance has
been reported in ruminants worldwide, very little is known about anthelmintic resistance in alpacas. The present
study was carried out to confirm a suspected case of anthelmintic resistance in Haemonchus contortus in alpacas in
Australia.
Methods: Post mortem examination of an alpaca was conducted to determine the cause of its death. To confirm a
suspected case of macrocyclic lactone (ML) resistance in H. contortus in alpacas, a faecal egg count reduction test
(FECRT) was performed using closantel (7.5 mg/kg) and ivermectin (0.2 mg/kg). Nematode species were identified
by morphological and molecular methods.
Results: Post mortem examination of a 1-year-old female alpaca that had died following a brief period of lethargy,
anorexia and recumbency revealed severe anaemia, hypoproteinaemia and gastric parasitism by adult Haemonchus
contortus, despite recent abamectin (0.2 mg/kg) treatment. Based on these findings and the exclusive use of MLs in
the herd over the preceding six years, ML resistance in parasitic nematodes of alpacas on this farm was suspected.
FECRT revealed that the efficacy of closantel was 99% (95% CI 93-100), whereas that of ivermectin was 35% (95% CI
0-78), indicating that the treatment failure was likely due to the presence of ML-resistant nematodes. Larval culture
of faecal samples collected following ivermectin treatment consisted of 99% H. contortus and 1% Cooperia
oncophora, a result confirmed using a PCR assay.
Conclusions: This study provides the first evidence of ML resistance in H. contortus in alpacas in Australia. Based on
the extent of anthelmintic resistance in sheep gastrointestinal nematodes in Australia, veterinarians and alpaca
owners should be encouraged to implement integrated parasite management strategies to improve nematode
control in alpacas.
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In the last two decades, domesticated South American
Camelids (SACs), particularly llamas (Lama glama) and
alpacas (Lama pacos), have been farmed increasingly for
their fine fleece and adaptability to many climatic re-
gions. Smaller numbers are also kept as pets on ‘hobby’
farms [1]. There are now in excess of 90,000 alpacas reg-
istered in Australia, with more than 90% of these being
of the Huacaya breed [2].* Correspondence: jabbara@unimelb.edu.au
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reproduction in any medium, provided the orIn intensive farming contexts, parasitic nematodes can
cause substantial clinical and subclinical problems in
SACs, leading to economic loss from suboptimal pro-
duction of fibre, meat and/or leather [3]. Domesticated
alpacas often share pasture with other livestock species
such as sheep, and are grazed under more intensive
grazing conditions than in their native countries, factors
which significantly increase the probability of their ac-
quiring nematode infections [3-6]. Farmers regularly ad-
minister various classes of anthelmintics to alpacas to
control nematodes. Although anthelmintic resistance
has been reported in ruminants worldwide, very little is
known about anthelmintic resistance in SACs [7-9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(ML) resistance in Haemonchus contortus on an alpaca
farm in Australia, following several deaths of mature al-




The investigation was carried out on a farm with a
herd of 115 alpacas in the Yarra Valley, north-east of
Melbourne (37°39′22″S 145°30′50″E), Victoria. This re-
gion has an average annual rainfall of 1170 mm, with mild
summers and cool winters. Alpacas in the herd were rou-
tinely vaccinated against clostridial diseases (caused by
Clostridium perfringens type D, C. tetani, C. novyi type B,
C. septicum and C. chauvoei) and were drenched orally
with macrocyclic lactone (ML) anthelmintics, once each
summer and once each winter. Abamectin had been used
in the previous two years and moxidectin for four years
prior to that. No other anthelmintic classes had been used
on the farm in recent years. Replacement alpacas were
bred on the farm or acquired from other parts of
Australia. Alpacas introduced into the herd were treated
with oral abamectin (0.2 mg/kg) and kept in isolation for
one week. No other species of livestock were kept on the
farm.
Case history
The present investigation was instigated in September
2012 after the deaths of eight adult alpacas in the herd
over the preceding five months. Five animals had died in
late autumn (April and May) and three others in early
spring (September). Affected animals were usually in
good condition but became lethargic, weak and recum-
bent, and thence died in one to two days, despite treat-
ment with oral abamectin (0.2 mg/kg) and various
injectable antibiotics. Field post mortem examinations
conducted by a local veterinarian revealed that all of the
affected animals were anaemic. The carcase of a ninth ani-
mal, 1-year-old female Huacaya alpaca weighing 47 kg,
was submitted to the Veterinary Clinical Centre, The
University of Melbourne for post mortem examination.
Based on post mortem findings of severe anaemia,
hypoproteinaemia and gastric parasitism by adult H.
contortus, and the drenching history of the herd, we
suspected a problem associated with ML resistance.
Faecal egg reduction test
A faecal egg count reduction test (FECRT) was performed
on the farm, according to the World Association for the
Advancement of Veterinary Parasitology (WAAVP) guide-
lines for evaluation of anthelmintic efficacy in ruminants
[10]. In an attempt to prevent further deaths of alpacas,
the farmer had treated most animals on the farm withClosicare with Selenium® (closantel 37.5 g/L, selenium
0.5 g/L; Virbac Animal Health Pty Ltd, New South Wales
(NSW), Australia) at a dose rate of 1 mL/5 kg body
weight, so that only 23 adult female alpacas were available
for the FECRT. These animals were randomly allocated to
three groups for treatment with Ivomec Liquid for Sheep®
(ivermectin 0.8 g/L; Merial Pty Ltd, NSW, Australia) or
Closicare with Selenium or as a control group: Group 1 –
8 animals, Ivomec at 1 mL/4 kg body weight; Group 2 – 8
animals, Closicare with Selenium at 1 mL/5 kg; Group 3 –
7 animals, untreated control. The anthelmintics were
administered orally at the dose for the heaviest animal
in the group. Individual faecal samples were collected
from the rectum prior to treatment (day 0) and 11 days
after treatment. Faecal egg counts of both thick-shelled
strongylid and Nematodirus eggs were determined using a
modified McMaster technique [11], with a sensitivity of 30
eggs per gram of faeces (EPG). The reduction in EPG was
calculated using the program RESO FECRT v4.0 (http://
www.vetsci.usyd.edu.au/sheepwormcontrol/index.html). A
population of strongylid nematodes was defined as resist-
ant to an anthelmintic if the reduction in EPG was less
than 95% and the lower 95% confidence limit of the per-
centage of reduction was less than 90% [12].
Identification of nematode species
Standard faecal larval cultures were performed for each
of the three groups in the FECRT, using a 20 g compos-
ite of individual faecal samples incubated at 25°C for
10 days [13].
In addition, we used a polymerase chain reaction
(PCR)-coupled method [14] for the unequivocal identifi-
cation of trichostrongylid eggs present in alpaca faeces
on the farm under investigation. In brief, genomic DNAs
from strongylid eggs, isolated from pooled faecal sam-
ples from each group, were extracted using PowerSoil®
DNA Isolation Kit (MO BIO Labs, Inc., California,
USA) and specifically tested for Chabertia ovina,
Cooperia oncophora, H. contortus, Oesophagostomum
columbianum, O. venulosum, Teladorsagia circumcincta
and Trichostrongylus spp. [14]. Negative (no DNA) and
known positive controls were included in each set of
PCRs. Amplicons were subjected to 1.5% agarose gel
electrophoresis, automated DNA sequencing (BigDye®
Terminator v.3.1 chemistry, Applied Biosystems, Foster
City, California, USA), and BLASTn analysis (http://blast.
ncbi.nlm.nih.gov) to establish the ‘top hits’ to all nucleo-
tide sequences available in current databases.
Results
Post mortem examination
A 1-year-old female Huacaya submitted for post mortem
examination had been sick for several weeks and had
received oral abamectin at the sheep dose rate of
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ings included severe pallor of the oral and conjunctival
mucosae, skeletal musculature, liver and kidneys and re-
markably watery blood within the heart and major blood
vessels. These changes were consistent with severe an-
aemia. There was mild submandibular oedema and severe
subcutaneous oedema (up to a 4 cm depth) in dependent
areas along the ventral trunk and radiating down the
proximal fore and hind limbs (Figure 1A). Moderately
severe hydrothorax, hydropericardium and ascites were
also present (Figure 1B-D) and there was moderately
severe diffuse pulmonary oedema and mild oedematous
distension of the soft tissues of the larynx. The oedema
was suspected to be referable to hypoalbuminaemia.
However, determination of an accurate plasma protein
concentration and a packed cell volume could not be
undertaken due to post mortem lysis of erythrocytes.
A small number of adult nematodes were observed
on the mucosal surface of the third compartment of
the stomach (Figure 1E). A total worm count revealed
H. contortus (n = 460) in this gastric compartment butFigure 1 Lesions in an alpaca that died of chronic haemonchosis. A, s
compression atelectasis of the cranioventral lungs and diffuse pulmonary o
fibrin coagulum; E, adult Haemonchus contortus on the mucosal surface ofno worms were found in the duodenum and proximal
jejunum. An egg count performed on a sample of rec-
tal faeces revealed 6,600 thick-shelled strongylid eggs
per gram. Histological evaluation of the viscera revealed
no other significant disease process and the cause of
death was concluded to be severe haemorrhagic anaemia
and hypoproteinaemia referable to the gastric nematode
infestation.
Faecal egg count reduction test and species identification
Analysis of day 0 FECs revealed that the animals in the
ivermectin group had low egg counts. As no other un-
treated animals were available on the farm, the control
animals were treated with ivermectin on day 11 and fae-
cal samples were collected 15 days later (day 26). The ef-
ficacy of ivermectin was calculated as the percentage
change in mean FEC between day 11 and day 26. The
results of the FECRT performed on the alpaca farm are
presented in Table 1. The efficacies of closantel and iver-
mectin were 99% (95% confidence interval (CI): 93-100%)
and 35% (95% CI: 0-78%), respectively.evere subcutaneous oedema over a stifle joint; B, hydrothorax with
edema; C, serosanguineous ascites; D, hydropericardium with a fresh
the third compartment of the stomach.
Table 1 Faecal egg count reduction test on an alpaca




(95% CI*)Day 0 Day 14
Control 797 ± 798 434 ± 419 -
Closantel 518 ± 738 5 ± 11 99% (93–100%)
Ivermectin 434 ± 419 283 ± 264 35% (0–78%)
Faecal egg counts (eggs per gram (EPG) ± standard deviation) and percentage
faecal egg count reduction (FECR%) in alpacas treated with two anthelmintics.
*CI = confidence internal.
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from the pre-treatment samples were H. contortus, with
smaller percentages of C. oncophora (11%), Nematodirus
spp. (2.5%) and Trichostrongylus spp. (4.5%). After treat-
ment with ivermectin, 99% of the larvae in the faecal sam-
ple were H. contortus and 1% were Cooperia oncophora.
Small numbers of H. contortus, C. oncophora, Nematodirus
spp. and Trichostrongylus spp. larvae were recovered from
a pooled faecal culture from alpacas treated with closantel,
although the number was insufficient to reliably calculate
the species proportions in the sample.
Genus-specific PCR from eggs from pooled faeces
from each group followed by the sequencing of amplicons
and analysis of the ITS-2 sequence data revealed the
presence of C. onchophora, H. contortus and T. axei,
based on comparisons with corresponding well-defined
ITS-2 reference sequences [GenBank accession numbers
JN128897, AJ544463 and AY439026 for H. contortus,
C. onchophora and T. axei, respectively] available in the
GenBank database.
Discussion
Resistance in major gastrointestinal nematodes (GINs)
of sheep against all major classes of anthelmintics is well
documented in Australia [15-17]. However, almost noth-
ing is known about the susceptibility of alpaca GINs to
anthelmintics and the widespread use of a limited num-
ber of compounds to control GIN in alpacas increases
the risk of development of anthelmintic resistance. Our
report is the first documented evidence of anthelmintic
resistance in alpacas in Australia, and follows reported
anthelmintic treatment failures in SACs in the USA [8]
and Belgium [9]. Oral and injectable MLs are very widely
used in alpacas in Australia to control GINs (J. Vaughan,
pers. comm.).
On the farm under study, morbidity and mortality of
alpacas over several months were suspected to be refer-
able to haemonchosis, despite long-term regular oral
drenching of all animals with abamectin and moxidectin.
The history and the post mortem findings strongly sug-
gested ML resistance had led to a failure of worm con-
trol on this farm. This suspicion was confirmed by the
FECRT, which indicated that ivermectin was only 35%effective, with this inferred resistance largely confined to
H. contortus. Such poor efficacy of ivermectin would
mean that the MLs used on the farm would have also
been ineffective in controlling other nematode (Cooperia
spp. and Trichostrongylus spp.) infections. Had ante
mortem FEC been performed on the moribund alpaca
on this farm, a FEC of 6,600 EPG in an animal drenched
regularly with MLs should have raised suspicions of a
failure of worm control, even before the FECRT was
conducted.
A number of factors might have contributed to the de-
velopment of ML resistance on this farm, including
those known to be associated with the development of
anthelmintic resistance in small ruminants [18]. Firstly,
MLs had been used exclusively on the property for at
least the last six years, and the only variation in anthelmin-
tic was between different types of MLs. Without the use of
other classes of anthelmintics to remove ML-resistant
worms, it could be expected that the prevalence of ML-
resistant worms on the farm would steadily increase
over time. The selection pressure for drench resist-
ance in H. contortus may have also been increased by the
ecology of this species in this environment, since
Haemonchus larvae survive poorly on pasture during cool
winters [19], leaving a small population of ‘refugia’ from
the winter treatments [20]. Secondly, the pharmacokinetic
properties of MLs in alpacas are not well described, and
inappropriate dosing may have contributed to the devel-
opment of ML resistance. No anthelmintics are registered
for use in alpacas in Australia, and the animals on this
farm received oral doses at sheep dose rates, although
some authors suggest that alpacas should receive 1.5 times
the dose rate of MLs for sheep [8,21]. Off-label anthelmin-
tic use is further complicated by the observation that dif-
ferent formulations of orally administered compounds
affect absorption in SACs [22] and those other anthelmin-
tic classes require even greater dose rates than those used
in sheep [23]. Scales were not available on the farm, and
under-dosing of anthelmintics might also have contrib-
uted to the development of anthelmintic resistance on this
farm. Our findings, along with previous studies, highlight
the need for determining the correct therapeutic doses of
various anthelmintics in SACs.
Although these factors might explain how the observed
anthelmintic resistance developed, an alternative proposal
is that drench-resistant worms were introduced with al-
pacas bought in from other farms [24,25]. Such a drench-
resistant worm population could have arisen in alpacas on
another property or developed in other co-grazing rumin-
ant species with subsequent cross-infection of alpacas
before they were moved to the current farm [3,26-28].
Frequent movement of alpacas amongst different farms
represents an important potential route of dissemination
of resistance.
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farm and the suspected death of multiple alpacas from
haemonchosis, it is interesting to note that few tested
animals had low packed cell volumes at the time of the
FECRT (data not shown). This may have reflected indi-
vidual differences in susceptibility to parasitism [29],
with the most heavily parasitised animals all dying before
we commenced our investigation. Alternatively, different
grazing management of groups of animals on the farm
may have affected pasture contamination with nematode
larvae or led to varying rates of infection amongst differ-
ent groups. Nonetheless, it is important to note that
most animals on the farm appeared to be clinically un-
affected despite the poor drench efficacy and disease in
their herd mates. Effective mechanisms are required for
monitoring SACs to identify the need for strategic and/
or tactical anthelmintic treatment, such as the Faffa
Malan's Chart (FAMACHA© system) used in sheep and
goats [30].
Most larvae in the post-treatment faecal cultures from
the alpacas treated with ivermectin were H. contortus, al-
though a small percentage of C. oncophora (1%) was also
present. ML resistance occurs in Cooperia spp. in cattle
in Australia [31], although it is difficult to assess the im-
portance of our observation in the present study.
Conclusions
This study provides the first evidence of ML resistance
in H. contortus in alpacas in Australia. Based on the extent
of anthelmintic resistance in sheep GINs in Australia,
veterinarians and alpaca owners should be encouraged to
implement integrated parasite management strategies to
improve nematode control in alpacas and manage anthel-
mintic resistance to avoid both fulminant disease and sub-
clinical parasitism.
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